Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 1
2007 2
2009 1
2014 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Sialorrhea: a management challenge.
Hockstein NG, Samadi DS, Gendron K, Handler SD. Hockstein NG, et al. Am Fam Physician. 2004 Jun 1;69(11):2628-34. Am Fam Physician. 2004. PMID: 15202698 Free article.
Sialorrhea (drooling or excessive salivation) is a common problem in neurologically impaired children (i.e., those with mental retardation or cerebral palsy) and in adults who have Parkinson's disease or have had a stroke. ...Treatment of sialorrhea is best managed …
Sialorrhea (drooling or excessive salivation) is a common problem in neurologically impaired children (i.e., those with mental …
Optimizing pharmacologic treatment for ALS to improve outcomes and quality of life.
Lynch K. Lynch K. Am J Manag Care. 2023 Jun;29(7 Suppl):S112-S119. doi: 10.37765/ajmc.2023.89389. Am J Manag Care. 2023. PMID: 37433092 Free article.
Therapy selection is based largely upon patient characteristics, as guidelines have not been updated since the recent approval of PB/TURSO or accelerated approval of tofersen. Managing ALS symptomatically is important to improve patients' quality of life. Although evidence …
Therapy selection is based largely upon patient characteristics, as guidelines have not been updated since the recent approval of PB/ …
Drug treatment of non-motor symptoms in Parkinson's disease.
Müller T. Müller T. Expert Opin Pharmacother. 2002 Apr;3(4):381-8. doi: 10.1517/14656566.3.4.381. Expert Opin Pharmacother. 2002. PMID: 11934340 Review.
Autonomic features, such as seborrhoea, hyperhidrosis, orthostatic hypotension, excessive salivation, bladder dysfunction and GI disturbances, and neuropsychiatric symptoms, such as depression, sleep disorders, psychosis and dementia, appear in the course of Parkins …
Autonomic features, such as seborrhoea, hyperhidrosis, orthostatic hypotension, excessive salivation, bladder dysfunction and …
Review of oral appliances for treatment of sleep-disordered breathing.
Hoffstein V. Hoffstein V. Sleep Breath. 2007 Mar;11(1):1-22. doi: 10.1007/s11325-006-0084-8. Sleep Breath. 2007. PMID: 17136406 Free PMC article. Review.
Between 1982 and 2006, there were 89 distinct publications dealing with oral appliance therapy involving a total of 3,027 patients, which reported results of sleep studies performed with and without the appliance. ...Side effects are relatively minor but frequent. The most …
Between 1982 and 2006, there were 89 distinct publications dealing with oral appliance therapy involving a total of 3,027 patients, w …
The role of oral appliance therapy in the treatment of obstructive sleep apnea.
Ferguson KA. Ferguson KA. Clin Chest Med. 2003 Jun;24(2):355-64. doi: 10.1016/s0272-5231(03)00015-7. Clin Chest Med. 2003. PMID: 12800789 Review.
Most patients report improvements in sleep quality and excessive daytime sleepiness. Short-term side effects are generally minor and are related to excessive salivation, jaw and tooth discomfort, and occasional joint discomfort. These symptoms may lead to dis …
Most patients report improvements in sleep quality and excessive daytime sleepiness. Short-term side effects are generally minor and …
Salivary gland application of botulinum toxin for the treatment of sialorrhea.
Fuster Torres MA, Berini Aytés L, Gay Escoda C. Fuster Torres MA, et al. Med Oral Patol Oral Cir Bucal. 2007 Nov 1;12(7):E511-7. Med Oral Patol Oral Cir Bucal. 2007. PMID: 17978775 Free article. Review.
Sialorrhea or excessive salivation, and drooling, are common and disabling manifestations in different neurological disorders. ...A reduction was observed in the production of saliva following these injections, and the duration of the therapeutic effect was 1 …
Sialorrhea or excessive salivation, and drooling, are common and disabling manifestations in different neurological disorders. …
Controlling sialorrhoea: a review of available treatment options.
Potulska A, Friedman A. Potulska A, et al. Expert Opin Pharmacother. 2005 Aug;6(9):1551-4. doi: 10.1517/14656566.6.9.1551. Expert Opin Pharmacother. 2005. PMID: 16086642 Review.
Sialorrhoea (drooling or excessive salivation) is a common symptom of many neurological diseases (e.g., amyotropic lateral sclerosis, cerebral palsy and Parkinson's disease) and otolaryngologic diseases (tumours of upper aerodigestive tract). ...
Sialorrhoea (drooling or excessive salivation) is a common symptom of many neurological diseases (e.g., amyotropic lateral scl …
Determinants of early medical management of nausea and vomiting of pregnancy.
Lacasse A, Rey E, Ferreira E, Morin C, Bérard A. Lacasse A, et al. Birth. 2009 Mar;36(1):70-7. doi: 10.1111/j.1523-536X.2008.00297.x. Birth. 2009. PMID: 19278386
Variables associated with an increased likelihood of women receiving an antiemetic prescription included nausea and vomiting severity, excessive salivation, previous antiemetic use, and work status. CONCLUSIONS: Health practitioners can improve their management of n …
Variables associated with an increased likelihood of women receiving an antiemetic prescription included nausea and vomiting severity, ex …
Polymorphism in alpha 2A adrenergic receptor gene is associated with sialorrhea in schizophrenia patients on clozapine treatment.
Solismaa A, Kampman O, Seppälä N, Viikki M, Mäkelä KM, Mononen N, Lehtimäki T, Leinonen E. Solismaa A, et al. Hum Psychopharmacol. 2014 Jul;29(4):336-41. doi: 10.1002/hup.2408. Epub 2014 May 19. Hum Psychopharmacol. 2014. PMID: 25163438
Twenty-six of these patients had previously been on medication to treat CIS. Comparisons of the genotypes between patients with excessive versus non-excessive salivation were analysed. Genotype distributions between patients and control group and haplotypes w …
Twenty-six of these patients had previously been on medication to treat CIS. Comparisons of the genotypes between patients with excessive …